oxazoles has been researched along with pd 0325901 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chatterjee, SS; Cukuroglu, E; DasGupta, R; Gocha, T; Göke, J; Saj, A; Zhang, X; Zhu, B | 1 |
Cheng, SY; Lee, WK; Park, S; Zhu, X | 1 |
2 other study(ies) available for oxazoles and pd 0325901
Article | Year |
---|---|
Disrupting Interactions Between β-Catenin and Activating TCFs Reconstitutes Ground State Pluripotency in Mouse Embryonic Stem Cells.
Topics: Animals; Benzamides; beta Catenin; Biomarkers; Cell Differentiation; Cells, Cultured; Diphenylamine; Female; Hepatocyte Nuclear Factor 1-alpha; Mice; Mice, Inbred C57BL; Mouse Embryonic Stem Cells; Oxazoles; Pluripotent Stem Cells; Protein Binding; Pyridines; Pyrimidines; Transcription Factor 7-Like 2 Protein; Transcriptome; Up-Regulation | 2017 |
Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Cycle Proteins; Cell Proliferation; Diphenylamine; Drug Synergism; Female; Humans; MAP Kinase Kinase 1; Mice; Mice, Nude; Oxazoles; Pyridines; Pyrroles; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Transcription Factors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |